
1. Technology overview
Anaut Inc. is a Japanese surgical AI company with its main office at Nishi-Shimbashi, Minato-ku, Tokyo, and a lab in Kawasaki. CEO Nao Kobayashi, a physician, began developing surgical AI in 2018, and the company was co-founded in 2020 with Kensuke Hosomi as COO.
EUREKA α is a surgical image recognition support program that estimates and highlights the position and area of key structures in real time during endoscopic surgery. Endoscope video enters a general-purpose workstation through an SDI cable and returns to the operating room monitor. Supported systems include Olympus VISERA ELITE II and III, da Vinci Xi and hinotori, covering stomach, colorectal, inguinal hernia and gynecologic procedures. Targets are loose connective tissue, pancreas and nerves.
2. Highlighted features & specifications
- Real-time highlighting: estimates and highlights key structures during surgery.
- LIVE mode: intraoperative analysis with a seek bar to review earlier frames.
- VIDEO mode: analysis of recorded surgical video.
- Adjustable display: transparency, blinking and highlight color can be changed.
- Broad endoscope support: Olympus VISERA ELITE II/III, da Vinci Xi and hinotori.
- EUREKA X: an education version for surgical training support.
3. Potential application
Gastrointestinal and gynecologic surgery units in large Vietnamese hospitals can use real-time highlighting during laparoscopic procedures. Training hospitals can use EUREKA X to teach anatomy recognition in recorded cases. Hospitals with robotic platforms can pair it with the compatible systems.
4. Benefits
Helps surgeons see loose connective tissue, pancreas and nerves during endoscopic procedures. Needs no network connection or preoperative information, only a cable connection to a workstation. Requires no additional intervention on the patient, per the product page. Display adjusts to model confidence at pixel level so the surgical field is less obstructed.
5. Market trends & opportunities
Endoscopic and robotic surgery is expanding, and intraoperative AI that marks anatomy is emerging as a safety and training aid. Japan approved the first such device in April 2024, and the company has opened an international website and a UK-region page. Vietnamese hospitals adopting laparoscopic and robotic surgery are a potential audience.
6. Other information
Founded 2020 in Tokyo (CEO Nao Kobayashi). EUREKA α received Japanese regulatory approval in April 2024, with pancreas and nerve highlighting added in January 2026. News on the site: international website launched 2026-06, head office relocation 2026-08, award 2026-10.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































